BIOTECHNOLOGY VALUE FUND L P - 31 Oct 2025 SCHEDULE 13G/A Report for NewcelX Ltd. Common Shares, par value CHF 0.05 (NLSP)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
NewcelX Ltd. Common Shares, par value CHF 0.05
Symbol
NLSP
Shares outstanding
4,788,667 shares
Disclosed Ownership
28,732 shares
Ownership
0.6%
Form type
SCHEDULE 13G/A
Filing time
04 Nov 2025, 18:57:03 UTC
Date of event
31 Oct 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 0.3% 15,196 0 15,196 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 0.3% 15,196 0 15,196 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 0.3% 11,746 0 11,746 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 0.3% 11,746 0 11,746 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.03% 1,334 0 1,334 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.03% 1,334 0 1,334 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 0.6% 26,942 0 26,942 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 0.6% 28,732 0 28,732 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 0.6% 28,732 0 28,732 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 0.6% 28,732 0 28,732 /s/ Mark N. Lampert Mark N. Lampert